Business partners

INDuSTRIAL PARTNERS

RaySearch’s systems and software products are developed in close collaboration with several leading cancer clinics, research institutes and medical device suppliers. Several key advances were made in 2021.

PhOTON ThERAPy

ACCURAY (uS) and RaySearch have a long-term collaboration agreement to advance and market fully integrated solutions that combine RayStation and RayCare with the Radixact® and CyberKnife® radiation therapy systems. A key milestone was achieved in September 2021 when the leading ChuV center in Switzerland treated its first patient using RayStation and CyberKnife. In October 2021, La Clinique Générale-Beaulieu, part of the Swiss Medical Network in Switzerland, announced that RayCare is now fully integrated and in clinical use with Radixact.

VARIAN (uS) and RaySearch entered into an interoperability agreement in 2020 under which Varian and RaySearch agreed to conduct verification and validation testing that, if successful, would recognize that RayCare is interoperable with Varian’s TrueBeam® linear accelerators, something that will significantly expand the market potential of RayCare. The tests have started in 2022 and RaySearch is looking forward to the clinical introduction if testing is successful.

CARBON ION ThERAPy

TOSHIBA (JAPAN) and yamagata university hospital jointly chose RayStation for the new carbon ion therapy center that opened at yamagata university hospital in early 2021. Shortly thereafter, the clinic treated its first patient using RayStation and Toshiba’s treatment delivery system. yamagata thus became the first carbon ion therapy center in Japan to use RayStation.

Varian

PROTON ThERAPy

IBA (BELGIuM), a world leader in proton therapy solutions, entered into a long-term strategic collaboration with RaySearch in 2016. RaySearch has since adapted RayStation and RayCare to IBA’s products in order to offer a comprehensive hardware and software solution. In autumn 2021, it was announced that the collaboration on fLASh therapy planning, proton arc therapy and treatment planning methods would be expanded to enable better management of moving tumors during radiation therapy due to, for example, respiratory motion.

MEVION MEDICAL SYSTEMS (uS) is a leading manufacturer of compact proton therapy systems and has been collaborating with RaySearch since 2014. RayStation supports IMPT planning for Mevion’s hyPERSCAN system and as part of their ongoing collaboration, RaySearch and Mevion will also explore advanced treatment planning techniques for fLASh delivery.

IMAGING

CANON MEDICAL SYSTEMS (JAPAN) develops diagnostic imaging systems including CT, MRI, ultrasound, X-ray systems and clinical laboratory systems. The partnership will result in products that enable more efficient workflows for virtual simulations. These tools for visualization and planning are expected to help the clinics determine the size and location of tumors, and to plan the direction of the beam and isocenter. In spring 2021, this collaboration was expanded to also include sales in the uS market.

BRAChyThERAPy

ECKERT & ZIEGLER BEBIG (GERMANy) is a leading European provider of products for brachytherapy, a type of radiation therapy in which small radioactive implants are put inside the body or near the tumor. Brachytherapy is most commonly used to treat prostate cancer, but can also be used for many other areas, such as brain cancer, eye cancer, lung cancer and skin cancer. E&Z Bebig became a RaySearch partner in 2018, and RayStation has been integrated with Eckert & Ziegler BEBIG’s brachytherapy system since 2020.

CLINICAL PARTNERS

HEIDELBERG AND MARBURG ION BEAM THERAPY CENTER (GERMANy) These two prestigious institutions in Germany are active in proton and carbon ion therapy. heidelberg university hospital became a RayCare partner in 2018. RayStation was selected jointly by hIT, MIT, heidelberg university hospital and the German Cancer Research Center. RayStation is the world’s first commercial treatment planning system that supports helium ion therapy and the Ion Beam Therapy Center at heidelberg university hospital was first in Europe to offer helium ion therapy using RayStation. heidelberg has been using RayCare together with RayStation since 2019. In 2021, this center was first in the world to treat a patient with helium ion therapy using pencil-beam scanning.

IRIDIUM CANCER NETWORK (BELGIuM) ICN is a network providing highly specialized radiation oncology for three hospital networks in the larger region of Antwerp, representing 18 hospital locations. ICN became a RaySearch partner in 2015 and was first to use RayCare clinically, just two months after the release. Since autumn 2021, the network has been working to implement RayCare as the only oncology information system for all of the linear accelerators in all of its centers.

SWISS MEDICAL NETWORK (SWITZERLAND) is one of Switzerland’s two leading private clinic groups. The clinics provide first-class hospital treatment in all three of the country’s language regions. Swiss Medical Network became a RaySearch partner in 2019 and has been using RayCare clinically since September 2020. In October 2021, one of the network’s clinics was first in the world to treat a patient with RayStation, RayCare and Accuray’s Radixact system.

PROVISION HEALTHCARE (uS) in Knoxville, became the first clinic in the world in 2014 to use RayStation for clinical proton therapy. Provision became a RayCare partner in 2017. Provision has been using RaySearch products exclusively since 2018 to manage all patient treatments, including treatment session management with RayTreat. UNIVERSITY HEALTH NETWORK (CANADA) has had a successful and long-lasting relationship with RaySearch via the Princess Margaret Cancer Centre in Toronto. Princess Margaret is one of the largest comprehensive cancer treatment facilities in the world and has one of the world’s largest RayStation installations.

UNIVERSITY MEDICAL CENTER GRONINGEN (NEThERLANDS) was the first center in the Netherlands to offer proton therapy in addition to advanced photon therapy. The center is equipped with IBA’s ProteusPLuS two-gantry room configuration, Pencil-Beam Scanning and Cone-Beam CT capabilities. uMCG has played a key role in development of the RayCare oncology information system and has been using RayCare clinically since 2019.

MEDAUSTRON (AuSTRIA) in Wiener Neustadt in Austria is a leading center for ion beam therapy and research, specialized in advanced cancer treatments with protons and carbon ions. MedAustron has been using RayStation for treatment planning since 2016 and is working to use software from RaySearch exclusively. In spring 2022, MedAustron will be first in the world to use RayCommand clinically.

UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER(uS) began using RayStation in 2013, initially with conventional linacs, and later with the TomoTherapy system in close collaboration with RaySearch and Accuray. The center now uses RayStation for all treatment planning. In 2017, RaySearch entered into a collaboration with MD Anderson to enable clinical implementation of RayCare in a complex and large-scale environment. In 2018, the parties announced a strategic alliance with the aim of enhancing cancer radiation therapy by using adaptive radiation therapy, and by streamlining and automating the planning of workflows.

UNIVERSITY OF WISCONSIN-MADISON (uS) became a RayCare partner in 2017. RayCare supports the institution’s strong multidisciplinary approach to cancer care and its focus on cutting-edge techniques. The university has a long tradition of radiation therapy and has also implemented RayStation as its treatment planning system.